Real World Evidence Solutions Market to Reach USD 5 Billion Globally by 2031 at 13.7% CAGR, Says Allied Market Research
Increase in the prevalence of cancer and chronic diseases, surge in adoption of technologically advanced real-world evidence solutions, and rise in number of pipeline drugs drive the growth